Juan A. Marchal - Search Results

Year	Number of Results
2002	3
2003	3
2004	2
2005	3
2006	4
2007	7
2008	6
2009	2
2010	11
2011	19
2012	7
2013	10
2014	7
2015	4
2016	7
2017	8
2018	12
2019	14
2020	25
2021	15
2022	7

1

CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.

Olivares-Urbano MA, Griñán-Lisón C, Marchal JA, Núñez MI. Olivares-Urbano MA, et al. Cells. 2020 Jul 9;9(7):1651. doi: 10.3390/cells9071651. Cells. 2020. PMID: 32660072 Free PMC article. Review.

2

Cancer: a mirrored room between tumor bulk and tumor microenvironment.

Hernández-Camarero P, López-Ruiz E, Marchal JA, Perán M. Hernández-Camarero P, et al. J Exp Clin Cancer Res. 2021 Jun 28;40(1):217. doi: 10.1186/s13046-021-02022-5. J Exp Clin Cancer Res. 2021. PMID: 34183054 Free PMC article. Review.

3

Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges.

Martínez-Molina E, Chocarro-Wrona C, Martínez-Moreno D, Marchal JA, Boulaiz H. Martínez-Molina E, et al. Among authors: marchal ja. Pharmaceutics. 2020 Nov 3;12(11):1051. doi: 10.3390/pharmaceutics12111051. Pharmaceutics. 2020. PMID: 33153183 Free PMC article. Review.

4

Evolution of Metastasis Study Models toward Metastasis-On-A-Chip: The Ultimate Model?

Ruiz-Espigares J, Nieto D, Moroni L, Jiménez G, Marchal JA. Ruiz-Espigares J, et al. Small. 2021 Apr;17(14):e2006009. doi: 10.1002/smll.202006009. Epub 2021 Mar 11. Small. 2021. PMID: 33705602 Review.

5

Models of Disease.

Jiménez G, López-Ruiz E, Antich C, Chocarro-Wrona C, Marchal JA. Jiménez G, et al. Adv Exp Med Biol. 2018;1059:331-350. doi: 10.1007/978-3-319-76735-2_15. Adv Exp Med Biol. 2018. PMID: 29736581

6

Exosome: A New Player in Translational Nanomedicine.

Aheget H, Tristán-Manzano M, Mazini L, Cortijo-Gutierrez M, Galindo-Moreno P, Herrera C, Martin F, Marchal JA, Benabdellah K. Aheget H, et al. J Clin Med. 2020 Jul 26;9(8):2380. doi: 10.3390/jcm9082380. J Clin Med. 2020. PMID: 32722531 Free PMC article. Review.

7

A Worldwide Overview of Regulatory Frameworks for Tissue-Based Products.

Oberweis CV, Marchal JA, López-Ruiz E, Gálvez-Martín P. Oberweis CV, et al. Tissue Eng Part B Rev. 2020 Apr;26(2):181-196. doi: 10.1089/ten.TEB.2019.0315. Epub 2020 Jan 28. Tissue Eng Part B Rev. 2020. PMID: 31910099 Review.

8

Trypsinogen and chymotrypsinogen: potent anti-tumor agents.

González-Titos A, Hernández-Camarero P, Barungi S, Marchal JA, Kenyon J, Perán M. González-Titos A, et al. Expert Opin Biol Ther. 2021 Dec;21(12):1609-1621. doi: 10.1080/14712598.2021.1922666. Epub 2021 May 11. Expert Opin Biol Ther. 2021. PMID: 33896307

9

Transdifferentiation: why and how?

Perán M, Marchal JA, Rodríguez-Serrano F, Alvarez P, Aránega A. Perán M, et al. Cell Biol Int. 2011 Apr;35(4):373-9. doi: 10.1042/CBI20100445. Cell Biol Int. 2011. PMID: 21413928 Review.

10

Smart Drug-Delivery Systems for Cancer Nanotherapy.

Sanchez-Moreno P, Ortega-Vinuesa JL, Peula-Garcia JM, Marchal JA, Boulaiz H. Sanchez-Moreno P, et al. Curr Drug Targets. 2018 Feb 19;19(4):339-359. doi: 10.2174/1389450117666160527142544. Curr Drug Targets. 2018. PMID: 27231107 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results